Cargando…
PEX-168 improves insulin resistance, inflammatory response and adipokines in simple obese mice: a mechanistic exploration
BACKGROUND: Polyethylene glycol loxenatide (PEX-168) is a new antidiabetic drug; as such, there are not yet any reports on its weight loss effect. Therefore, this trial was designed to investigate the effect of PEX-168 on simple obese mice. METHODS: Thirty healthy male C57BL/6 mice were randomly sel...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686575/ https://www.ncbi.nlm.nih.gov/pubmed/34923973 http://dx.doi.org/10.1186/s12902-021-00908-1 |